We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go: Extended investment: £295,000
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go: Extended investment: Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go: TBC investment: £127,001
Yolk, also known as In One Basket Limited, is a pioneering company revolutionizing the food and coffee experience for people on the move. They provide high-quality sandwiches, salads, and improved breakfast options without the premium cost, boasting five successful locations in London and three upcoming openings in the second half of 2023
days to go: TBC investment: Withheld
The Five Points Brewing Company (TFPBC) is one of London's best-known craft breweries that brews modern, flavourful, craft beer, The company asserts that its beers are stocked nationwide in pubs and across major chains like Waitrose, Tesco and Nando's. TFPBC claims that it has grown from £173,000 worth of sales in 2013 to £4.8 million in 2019. The company's first pub, The Pembury Tavern, has been graced with awards and recommendations from multiple entities. TFPBC argues that it has developed its e-commerce site in the wake of COVID-19 achieving online sales of over £300,000 from selling three million pints in draught, bottle and can form since March 2020. It also won the Champion Beer Of London 2019 Award. The company will use the investment to open its new on-site taproom with a large outdoor area for beer sales direct to the public, build a new flagship brewery site in Hackney, drive new sources of revenue whilst reducing costs, and maintain its commitment to East London
days to go: Expired investment: £841,392
Cheesegeek strives to ensure that local cheeses reach a global audience. With backing from Dragon and Steven Bartlett, they are pursuing funding to advance their business model beyond merely curated cheese boxes (having dispatched over 100,000) and transition into a technology-focused specialist in cheese innovation, employing an omnichannel strategy.
days to go: Expired investment: £427,570
A food delivery service offering calorie-counted and high-protein meals for those focused on health and fitness. Gym Food is based in London and is now raising funds to open in three more locations across the city. The company has been achieving average weekly sales of £23k in the November 2017/18 trading period. Gym Food does not have any storefronts, or shop fits and instead trades exclusively via deliveries. The business has received a rating of 4.4 out of 5 on UberEats and 94% on Deliveroo.
days to go: Expired investment: £231,170
PlusGuidance is an online counselling and therapy platform. PlusGuidance gives users access to hundred of therapists all over the world so you can find your perfect therapist without being restricted by geography.
days to go: Expired investment: £54,690
Redwell Brewing is a small batch independent brewery offering an entire range which is audited gluten-free and certified vegan. Well known for its handmade beer, the brewery’s booming taproom and events space which opened in 2018 on a shoestring budget of £200 is also a well-loved destination with sales of £30,000 in December 2018 alone. The brewery has partnered with several retailers and wholesalers, including creating an own-label craft beer for ALDI. With focus on flavours and community, Redwell Brewing is constantly innovating and winning awards, such as three GOLDs in the World Beer Awards. With the proceeds, it's planning to expand its facilities and its range into on and off trading outlets beyond the UK. 
days to go: Expired investment: £75,650
Fruity Beauties have created Vit C fuelled ice pops to provide a fun and nutritious burst of life. Fruity Beauties have all natural flavours as they are naturally sweetened by grape juice and give you 100% of your daily Vitamin C. 
days to go: Expired investment: £21,852
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph